Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...

An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.They’re in short supply, ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

He opined that the medical and legal risk of putting patients on a compounded version of a weight loss medication like semaglutide is significant, citing the FDA’s concerns around potential ...

Prescription weight loss drugs have become so popular in ... Researchers who ordered and tested compounded semaglutide found some were contaminated and others contained more of the active ...